Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 71 | 2024 | 1570 | 11.500 |
Why?
|
Epoprostenol | 17 | 2024 | 248 | 6.350 |
Why?
|
Exercise Tolerance | 25 | 2024 | 830 | 4.220 |
Why?
|
Pulmonary Artery | 28 | 2024 | 1921 | 3.510 |
Why?
|
Lung Diseases, Interstitial | 11 | 2024 | 911 | 3.500 |
Why?
|
Antihypertensive Agents | 19 | 2024 | 2061 | 2.880 |
Why?
|
Vascular Resistance | 20 | 2023 | 933 | 2.460 |
Why?
|
Ventricular Function, Right | 8 | 2024 | 610 | 2.240 |
Why?
|
Exercise Test | 25 | 2024 | 2128 | 2.180 |
Why?
|
Hyperoxia | 10 | 2010 | 250 | 2.010 |
Why?
|
Phosphodiesterase 5 Inhibitors | 5 | 2020 | 103 | 1.930 |
Why?
|
Ventricular Dysfunction, Right | 7 | 2021 | 615 | 1.370 |
Why?
|
Pulmonary Wedge Pressure | 12 | 2024 | 273 | 1.340 |
Why?
|
Hemodynamics | 15 | 2024 | 4174 | 1.250 |
Why?
|
Pulmonary Circulation | 9 | 2022 | 743 | 1.240 |
Why?
|
Stroke Volume | 15 | 2021 | 5523 | 1.240 |
Why?
|
Prostaglandins I | 2 | 2020 | 13 | 1.170 |
Why?
|
Dyspnea | 7 | 2021 | 1352 | 1.050 |
Why?
|
Ventricular Pressure | 4 | 2021 | 204 | 1.020 |
Why?
|
Interleukin-6 | 10 | 2009 | 3215 | 0.970 |
Why?
|
Recombinant Fusion Proteins | 6 | 2024 | 3735 | 0.930 |
Why?
|
Interleukin-11 | 6 | 2008 | 59 | 0.920 |
Why?
|
Heart Failure | 12 | 2021 | 11847 | 0.900 |
Why?
|
Diagnostic Techniques, Cardiovascular | 2 | 2016 | 152 | 0.860 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2022 | 62 | 0.790 |
Why?
|
Administration, Inhalation | 5 | 2024 | 1156 | 0.790 |
Why?
|
Tricuspid Valve | 4 | 2019 | 409 | 0.770 |
Why?
|
Transforming Growth Factor beta | 3 | 2024 | 1959 | 0.700 |
Why?
|
Exercise | 19 | 2023 | 5787 | 0.700 |
Why?
|
Heart Ventricles | 10 | 2021 | 3811 | 0.700 |
Why?
|
Infusion Pumps, Implantable | 2 | 2017 | 157 | 0.670 |
Why?
|
Tricuspid Valve Insufficiency | 3 | 2019 | 355 | 0.630 |
Why?
|
Gelsolin | 3 | 2008 | 189 | 0.620 |
Why?
|
Acute Lung Injury | 4 | 2010 | 367 | 0.620 |
Why?
|
Cytoprotection | 2 | 2009 | 200 | 0.610 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2061 | 0.610 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2021 | 461 | 0.610 |
Why?
|
Oxygen Consumption | 8 | 2024 | 1843 | 0.580 |
Why?
|
Lung | 17 | 2022 | 9994 | 0.570 |
Why?
|
Lung Diseases | 5 | 2017 | 1915 | 0.560 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 502 | 0.540 |
Why?
|
Pulmonary Alveoli | 2 | 2010 | 653 | 0.530 |
Why?
|
Pulmonary Medicine | 1 | 2018 | 221 | 0.520 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2024 | 3224 | 0.510 |
Why?
|
Oxygen | 12 | 2022 | 4193 | 0.470 |
Why?
|
Humans | 138 | 2024 | 760621 | 0.450 |
Why?
|
Endpoint Determination | 1 | 2015 | 597 | 0.420 |
Why?
|
Catheterization, Central Venous | 1 | 2017 | 526 | 0.400 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 926 | 0.400 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2017 | 498 | 0.390 |
Why?
|
Respiratory Function Tests | 4 | 2021 | 1683 | 0.380 |
Why?
|
Fatigue Syndrome, Chronic | 2 | 2023 | 215 | 0.370 |
Why?
|
Anticoagulants | 2 | 2017 | 4897 | 0.370 |
Why?
|
Ventricular Function, Left | 3 | 2019 | 3880 | 0.360 |
Why?
|
Treatment Outcome | 19 | 2024 | 65017 | 0.350 |
Why?
|
Double-Blind Method | 9 | 2024 | 12427 | 0.350 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2018 | 936 | 0.350 |
Why?
|
Aged | 56 | 2024 | 169152 | 0.340 |
Why?
|
Female | 82 | 2024 | 391270 | 0.330 |
Why?
|
Respiratory Mucosa | 3 | 2010 | 441 | 0.330 |
Why?
|
Middle Aged | 65 | 2024 | 220352 | 0.320 |
Why?
|
Male | 81 | 2024 | 359744 | 0.320 |
Why?
|
MAP Kinase Kinase Kinase 5 | 1 | 2008 | 20 | 0.320 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2009 | 71 | 0.320 |
Why?
|
Mitochondrial Proteins | 2 | 2019 | 979 | 0.320 |
Why?
|
Sulfones | 1 | 2011 | 447 | 0.310 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2008 | 106 | 0.310 |
Why?
|
bcl-2-Associated X Protein | 2 | 2009 | 282 | 0.310 |
Why?
|
DNA Fragmentation | 2 | 1999 | 237 | 0.310 |
Why?
|
Cell Membrane Permeability | 1 | 2010 | 575 | 0.310 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2009 | 1407 | 0.300 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 173 | 0.300 |
Why?
|
Hydrogen Peroxide | 3 | 2009 | 732 | 0.290 |
Why?
|
Signal Transduction | 9 | 2024 | 23376 | 0.280 |
Why?
|
Cardiology | 1 | 2018 | 1723 | 0.280 |
Why?
|
Disease Progression | 3 | 2022 | 13502 | 0.270 |
Why?
|
Pulmonary Gas Exchange | 6 | 2020 | 378 | 0.270 |
Why?
|
Calcium Channel Blockers | 2 | 2007 | 694 | 0.270 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 214 | 0.260 |
Why?
|
Prostaglandins | 1 | 2007 | 398 | 0.260 |
Why?
|
Echocardiography, Doppler | 3 | 2017 | 901 | 0.260 |
Why?
|
Caspase 3 | 1 | 2008 | 731 | 0.260 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2016 | 2128 | 0.250 |
Why?
|
GTP Phosphohydrolases | 1 | 2009 | 518 | 0.250 |
Why?
|
Protein C | 1 | 2005 | 133 | 0.250 |
Why?
|
Isoxazoles | 1 | 2007 | 230 | 0.250 |
Why?
|
Pulmonary Embolism | 3 | 2022 | 2543 | 0.240 |
Why?
|
Myocardium | 3 | 2017 | 4700 | 0.240 |
Why?
|
Piperazines | 2 | 2014 | 2525 | 0.240 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2008 | 316 | 0.230 |
Why?
|
Mice, Transgenic | 13 | 2012 | 9530 | 0.230 |
Why?
|
Adult | 52 | 2024 | 219994 | 0.220 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2014 | 1485 | 0.220 |
Why?
|
Activin Receptors, Type II | 1 | 2024 | 124 | 0.220 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 2003 | 28 | 0.220 |
Why?
|
Least-Squares Analysis | 2 | 2021 | 369 | 0.220 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2019 | 2895 | 0.220 |
Why?
|
Membrane Transport Proteins | 1 | 2009 | 1035 | 0.210 |
Why?
|
Shock, Septic | 2 | 2007 | 761 | 0.200 |
Why?
|
Thiophenes | 1 | 2007 | 587 | 0.200 |
Why?
|
Systole | 3 | 2021 | 947 | 0.200 |
Why?
|
Echocardiography | 8 | 2021 | 4981 | 0.200 |
Why?
|
Radionuclide Imaging | 13 | 2003 | 1975 | 0.200 |
Why?
|
Organizational Affiliation | 1 | 2001 | 34 | 0.200 |
Why?
|
Actins | 2 | 2008 | 2049 | 0.200 |
Why?
|
Matrix Metalloproteinase 8 | 1 | 2021 | 56 | 0.200 |
Why?
|
Infusions, Intravenous | 4 | 2017 | 2234 | 0.200 |
Why?
|
Perfusion Imaging | 2 | 2022 | 196 | 0.190 |
Why?
|
MicroRNAs | 5 | 2015 | 3790 | 0.190 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8056 | 0.190 |
Why?
|
Endothelial Cells | 8 | 2018 | 3539 | 0.190 |
Why?
|
Anaerobic Threshold | 2 | 2019 | 52 | 0.190 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1881 | 0.190 |
Why?
|
Connecticut | 1 | 2021 | 365 | 0.180 |
Why?
|
Medication Adherence | 1 | 2012 | 2165 | 0.180 |
Why?
|
Schistosomiasis | 1 | 2021 | 64 | 0.180 |
Why?
|
Recovery of Function | 2 | 2024 | 2985 | 0.180 |
Why?
|
Endothelium | 1 | 2003 | 764 | 0.180 |
Why?
|
Pulmonary Ventilation | 2 | 2019 | 371 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2448 | 0.180 |
Why?
|
Animals | 31 | 2024 | 167963 | 0.170 |
Why?
|
Public Sector | 1 | 2001 | 265 | 0.170 |
Why?
|
Retrospective Studies | 13 | 2024 | 80372 | 0.170 |
Why?
|
Cells, Cultured | 12 | 2019 | 18957 | 0.170 |
Why?
|
Vasodilator Agents | 4 | 2020 | 978 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 2864 | 0.170 |
Why?
|
Aldosterone | 2 | 2016 | 868 | 0.170 |
Why?
|
Iron-Sulfur Proteins | 2 | 2019 | 83 | 0.160 |
Why?
|
Respiratory Insufficiency | 2 | 2008 | 1231 | 0.160 |
Why?
|
Vital Capacity | 1 | 2021 | 965 | 0.160 |
Why?
|
Survival Rate | 8 | 2021 | 12808 | 0.160 |
Why?
|
Private Sector | 1 | 2001 | 397 | 0.150 |
Why?
|
Oxidants | 2 | 2009 | 169 | 0.150 |
Why?
|
Utah | 1 | 2018 | 131 | 0.150 |
Why?
|
Extracellular Matrix | 2 | 2016 | 1726 | 0.150 |
Why?
|
Up-Regulation | 4 | 2021 | 4122 | 0.150 |
Why?
|
Collagen Type III | 1 | 2018 | 91 | 0.150 |
Why?
|
Sepsis | 2 | 2010 | 2592 | 0.150 |
Why?
|
Cell Death | 3 | 2005 | 1672 | 0.150 |
Why?
|
Atrial Function | 1 | 2018 | 99 | 0.150 |
Why?
|
Anti-Infective Agents | 1 | 2005 | 981 | 0.150 |
Why?
|
Connective Tissue Diseases | 1 | 2021 | 286 | 0.150 |
Why?
|
Blood Pressure | 5 | 2017 | 8525 | 0.150 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39261 | 0.150 |
Why?
|
Oxidative Stress | 1 | 2009 | 3106 | 0.150 |
Why?
|
Mice | 22 | 2021 | 81208 | 0.140 |
Why?
|
Prognosis | 7 | 2021 | 29658 | 0.140 |
Why?
|
Time Factors | 11 | 2017 | 40165 | 0.140 |
Why?
|
Injections, Intra-Arterial | 1 | 2017 | 182 | 0.140 |
Why?
|
Verapamil | 1 | 1997 | 242 | 0.140 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2009 | 444 | 0.140 |
Why?
|
Guideline Adherence | 2 | 2022 | 2283 | 0.140 |
Why?
|
Ventricular Function | 2 | 2018 | 408 | 0.140 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2017 | 87 | 0.140 |
Why?
|
Microvessels | 1 | 2021 | 572 | 0.140 |
Why?
|
Gastric Emptying | 1 | 1999 | 243 | 0.140 |
Why?
|
Pyridines | 1 | 2008 | 2879 | 0.140 |
Why?
|
Quality of Life | 4 | 2023 | 13308 | 0.140 |
Why?
|
Mitochondria | 2 | 2009 | 3600 | 0.130 |
Why?
|
Echocardiography, Stress | 1 | 2017 | 134 | 0.130 |
Why?
|
Vascular Diseases | 2 | 2022 | 1182 | 0.130 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 322 | 0.130 |
Why?
|
DNA Damage | 1 | 2006 | 2442 | 0.130 |
Why?
|
Aortography | 1 | 2017 | 420 | 0.130 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 22023 | 0.130 |
Why?
|
Cardiac Output | 3 | 2015 | 838 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2024 | 2326 | 0.130 |
Why?
|
Aged, 80 and over | 9 | 2021 | 58995 | 0.130 |
Why?
|
Glycine | 1 | 2019 | 662 | 0.130 |
Why?
|
Propranolol | 1 | 1997 | 489 | 0.130 |
Why?
|
International Normalized Ratio | 1 | 2017 | 386 | 0.130 |
Why?
|
Sex Distribution | 1 | 2021 | 2295 | 0.130 |
Why?
|
World Health Organization | 1 | 2001 | 1312 | 0.130 |
Why?
|
Pneumonia, Pneumocystis | 1 | 1997 | 245 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10344 | 0.120 |
Why?
|
Drug Industry | 1 | 2001 | 789 | 0.120 |
Why?
|
Lipid Peroxidation | 3 | 2009 | 271 | 0.120 |
Why?
|
Cooperative Behavior | 2 | 2018 | 1500 | 0.120 |
Why?
|
Sulfur | 1 | 2015 | 163 | 0.120 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2017 | 265 | 0.120 |
Why?
|
Posture | 2 | 2017 | 953 | 0.120 |
Why?
|
Survival Analysis | 3 | 2024 | 10182 | 0.120 |
Why?
|
Heart | 6 | 2023 | 4393 | 0.110 |
Why?
|
Interdisciplinary Communication | 2 | 2018 | 934 | 0.110 |
Why?
|
Mechanotransduction, Cellular | 2 | 2016 | 530 | 0.110 |
Why?
|
Thallium Radioisotopes | 5 | 1993 | 138 | 0.110 |
Why?
|
Apoptosis | 6 | 2016 | 9501 | 0.110 |
Why?
|
Protein Transport | 2 | 2010 | 1964 | 0.110 |
Why?
|
Phenylpropionates | 1 | 2013 | 35 | 0.110 |
Why?
|
Cyclic GMP-Dependent Protein Kinases | 1 | 2013 | 28 | 0.110 |
Why?
|
Myocardial Contraction | 2 | 2018 | 1516 | 0.110 |
Why?
|
Feedback, Physiological | 1 | 2015 | 476 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2001 | 878 | 0.110 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1997 | 662 | 0.110 |
Why?
|
Community Pharmacy Services | 1 | 2012 | 50 | 0.100 |
Why?
|
Cytomegalovirus | 1 | 1997 | 755 | 0.100 |
Why?
|
Carbolines | 1 | 2014 | 288 | 0.100 |
Why?
|
Phosphoproteins | 2 | 2018 | 2440 | 0.100 |
Why?
|
Cell Proliferation | 5 | 2017 | 10446 | 0.100 |
Why?
|
Rats | 9 | 2021 | 23711 | 0.100 |
Why?
|
Heart Conduction System | 1 | 1997 | 1015 | 0.100 |
Why?
|
Vasoconstriction | 1 | 2014 | 593 | 0.100 |
Why?
|
Cardiac Output, Low | 1 | 2012 | 192 | 0.100 |
Why?
|
Membrane Proteins | 1 | 2009 | 7850 | 0.100 |
Why?
|
Purines | 2 | 2014 | 605 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 6 | 2021 | 8158 | 0.100 |
Why?
|
Cardiac Surgical Procedures | 1 | 2007 | 3620 | 0.100 |
Why?
|
Pyridazines | 1 | 2013 | 200 | 0.100 |
Why?
|
Drug Substitution | 1 | 2014 | 296 | 0.090 |
Why?
|
In Situ Nick-End Labeling | 3 | 2008 | 613 | 0.090 |
Why?
|
Risk Assessment | 3 | 2021 | 24123 | 0.090 |
Why?
|
Longitudinal Studies | 2 | 2022 | 14495 | 0.090 |
Why?
|
Fibrosis | 1 | 2018 | 2042 | 0.090 |
Why?
|
Dietary Fats | 1 | 1999 | 1992 | 0.090 |
Why?
|
Sulfonamides | 2 | 2014 | 1977 | 0.090 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2506 | 0.090 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2015 | 516 | 0.090 |
Why?
|
Medication Therapy Management | 1 | 2012 | 132 | 0.090 |
Why?
|
Patient Positioning | 3 | 2020 | 327 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 1215 | 0.090 |
Why?
|
Injections, Subcutaneous | 2 | 2023 | 680 | 0.090 |
Why?
|
Lung Injury | 2 | 2005 | 424 | 0.090 |
Why?
|
Hospital Mortality | 2 | 2015 | 5425 | 0.090 |
Why?
|
Respiration Disorders | 1 | 2013 | 368 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2021 | 10827 | 0.090 |
Why?
|
Cytomegalovirus Infections | 1 | 1997 | 831 | 0.090 |
Why?
|
Diuretics | 1 | 2013 | 613 | 0.090 |
Why?
|
Aorta | 1 | 2017 | 2039 | 0.090 |
Why?
|
Reproducibility of Results | 6 | 2017 | 20080 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20509 | 0.080 |
Why?
|
Nitric Oxide | 2 | 2022 | 2141 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2493 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1120 | 0.080 |
Why?
|
Spironolactone | 1 | 2013 | 411 | 0.080 |
Why?
|
Hyperaldosteronism | 1 | 2012 | 244 | 0.080 |
Why?
|
Catheterization, Peripheral | 1 | 2013 | 345 | 0.080 |
Why?
|
ROC Curve | 4 | 2018 | 3568 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1864 | 0.080 |
Why?
|
Administration, Oral | 2 | 2015 | 4035 | 0.080 |
Why?
|
Emergency Treatment | 1 | 2013 | 498 | 0.080 |
Why?
|
TNF Receptor-Associated Death Domain Protein | 1 | 2008 | 5 | 0.080 |
Why?
|
Bronchoalveolar Lavage Fluid | 4 | 2000 | 748 | 0.080 |
Why?
|
Phosphoserine | 1 | 2009 | 203 | 0.080 |
Why?
|
Blood Cells | 1 | 2010 | 305 | 0.080 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2008 | 57 | 0.080 |
Why?
|
Uteroglobin | 1 | 2008 | 56 | 0.080 |
Why?
|
DNA, Mitochondrial | 1 | 2013 | 858 | 0.080 |
Why?
|
Massachusetts | 1 | 2021 | 8803 | 0.080 |
Why?
|
Area Under Curve | 3 | 2017 | 1636 | 0.080 |
Why?
|
Blood Transfusion | 1 | 2015 | 1328 | 0.080 |
Why?
|
APACHE | 1 | 2008 | 267 | 0.080 |
Why?
|
Insurance Claim Review | 1 | 2012 | 738 | 0.080 |
Why?
|
Caspase 8 | 1 | 2008 | 189 | 0.080 |
Why?
|
Ultrasonography | 2 | 2018 | 5961 | 0.080 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2008 | 197 | 0.080 |
Why?
|
Arterioles | 1 | 2008 | 250 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 11903 | 0.070 |
Why?
|
Mitochondrial Membranes | 1 | 2009 | 172 | 0.070 |
Why?
|
Pilot Projects | 5 | 2018 | 8555 | 0.070 |
Why?
|
Placenta | 1 | 2017 | 1702 | 0.070 |
Why?
|
PPAR gamma | 3 | 2015 | 484 | 0.070 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2009 | 159 | 0.070 |
Why?
|
Macrophages, Alveolar | 1 | 2010 | 409 | 0.070 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 257 | 0.070 |
Why?
|
Asthma | 1 | 2006 | 6172 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2932 | 0.070 |
Why?
|
Swine | 1 | 2017 | 5899 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2019 | 4433 | 0.070 |
Why?
|
Sex Factors | 2 | 2021 | 10547 | 0.070 |
Why?
|
Gene Regulatory Networks | 2 | 2014 | 1741 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2058 | 0.070 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2016 | 686 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2511 | 0.070 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1097 | 0.070 |
Why?
|
Microtubule-Associated Proteins | 2 | 2008 | 1077 | 0.070 |
Why?
|
United States | 6 | 2021 | 72461 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1634 | 0.070 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 317 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2013 | 1535 | 0.070 |
Why?
|
Citrates | 2 | 2005 | 135 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 2873 | 0.070 |
Why?
|
Coculture Techniques | 1 | 2010 | 1342 | 0.070 |
Why?
|
Clinical Protocols | 1 | 2012 | 1440 | 0.070 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 687 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 3804 | 0.060 |
Why?
|
Potassium | 1 | 2010 | 1313 | 0.060 |
Why?
|
Endotoxemia | 1 | 2007 | 196 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 3442 | 0.060 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2005 | 68 | 0.060 |
Why?
|
Gallium | 1 | 2005 | 27 | 0.060 |
Why?
|
Hyperplasia | 1 | 2008 | 1155 | 0.060 |
Why?
|
Dioxoles | 1 | 2005 | 95 | 0.060 |
Why?
|
Severity of Illness Index | 6 | 2021 | 15840 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9280 | 0.060 |
Why?
|
Protein Interaction Mapping | 1 | 2009 | 617 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2018 | 3598 | 0.060 |
Why?
|
STAT3 Transcription Factor | 2 | 2014 | 877 | 0.060 |
Why?
|
Prospective Studies | 7 | 2021 | 54303 | 0.060 |
Why?
|
Intensive Care Units | 3 | 2013 | 3736 | 0.060 |
Why?
|
Thallium | 6 | 1987 | 100 | 0.060 |
Why?
|
Antioxidants | 3 | 2003 | 1667 | 0.060 |
Why?
|
Pregnancy | 2 | 2017 | 29749 | 0.060 |
Why?
|
Aortitis | 1 | 2005 | 74 | 0.060 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2005 | 1067 | 0.060 |
Why?
|
Cohort Studies | 4 | 2024 | 41335 | 0.060 |
Why?
|
Organ Specificity | 1 | 2009 | 1955 | 0.060 |
Why?
|
Interleukin-1beta | 1 | 2010 | 998 | 0.060 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1784 | 0.060 |
Why?
|
Protein Multimerization | 1 | 2009 | 983 | 0.060 |
Why?
|
Radioisotopes | 7 | 1987 | 495 | 0.060 |
Why?
|
Isoquinolines | 1 | 2005 | 353 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2008 | 1832 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2008 | 1246 | 0.060 |
Why?
|
Adenosine Triphosphate | 1 | 2010 | 1993 | 0.060 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2009 | 1135 | 0.060 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2005 | 415 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2006 | 1697 | 0.050 |
Why?
|
Thrombolytic Therapy | 2 | 2022 | 2108 | 0.050 |
Why?
|
DEAE-Dextran | 1 | 2023 | 9 | 0.050 |
Why?
|
Respiratory System Agents | 1 | 2023 | 30 | 0.050 |
Why?
|
Legionnaires' Disease | 1 | 2003 | 49 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2008 | 995 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2009 | 3602 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2012 | 7475 | 0.050 |
Why?
|
Systems Biology | 2 | 2018 | 482 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6465 | 0.050 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2006 | 404 | 0.050 |
Why?
|
Pyridostigmine Bromide | 1 | 2022 | 31 | 0.050 |
Why?
|
Gene Silencing | 1 | 2009 | 1513 | 0.050 |
Why?
|
Animals, Newborn | 1 | 2008 | 2672 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2015 | 2477 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21392 | 0.050 |
Why?
|
Stress, Physiological | 2 | 2009 | 1398 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 1974 | 0.050 |
Why?
|
Models, Biological | 2 | 2015 | 9467 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2008 | 3484 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18137 | 0.050 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2005 | 618 | 0.050 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2003 | 331 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3527 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2013 | 6498 | 0.050 |
Why?
|
Pneumonia | 2 | 2003 | 2131 | 0.050 |
Why?
|
Acute Disease | 3 | 2022 | 7269 | 0.050 |
Why?
|
Epithelium | 1 | 2006 | 1605 | 0.050 |
Why?
|
Rest | 2 | 2016 | 914 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3925 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15289 | 0.050 |
Why?
|
Physical Exertion | 3 | 2014 | 662 | 0.050 |
Why?
|
Resuscitation | 1 | 2005 | 661 | 0.050 |
Why?
|
Endocarditis | 1 | 2005 | 351 | 0.050 |
Why?
|
Trans-Activators | 2 | 2016 | 2860 | 0.040 |
Why?
|
Odds Ratio | 1 | 2012 | 9716 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 642 | 0.040 |
Why?
|
Cattle | 1 | 2006 | 3847 | 0.040 |
Why?
|
Young Adult | 6 | 2019 | 58741 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2006 | 1755 | 0.040 |
Why?
|
Computational Biology | 1 | 2012 | 3505 | 0.040 |
Why?
|
Phenotype | 1 | 2017 | 16546 | 0.040 |
Why?
|
Prosthesis-Related Infections | 1 | 2005 | 487 | 0.040 |
Why?
|
Adolescent | 9 | 2021 | 87810 | 0.040 |
Why?
|
Transcription Factors | 2 | 2016 | 12103 | 0.040 |
Why?
|
Organizational Policy | 1 | 2001 | 429 | 0.040 |
Why?
|
Carbon Monoxide | 1 | 2022 | 540 | 0.040 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2021 | 1717 | 0.040 |
Why?
|
DNA Replication | 1 | 2006 | 1412 | 0.040 |
Why?
|
Elasticity | 1 | 2021 | 652 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2005 | 12965 | 0.040 |
Why?
|
Registries | 1 | 2015 | 8469 | 0.040 |
Why?
|
Pneumonia, Viral | 1 | 1997 | 3205 | 0.040 |
Why?
|
Cell Respiration | 1 | 2019 | 202 | 0.040 |
Why?
|
Spirometry | 1 | 2001 | 924 | 0.040 |
Why?
|
Sarcoma | 2 | 2005 | 1786 | 0.040 |
Why?
|
Interleukin-13 | 1 | 2000 | 371 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2008 | 3663 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2008 | 4490 | 0.040 |
Why?
|
Smad3 Protein | 1 | 2018 | 167 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2000 | 673 | 0.040 |
Why?
|
Phosphorylation | 1 | 2009 | 8313 | 0.040 |
Why?
|
Logistic Models | 1 | 2012 | 13314 | 0.040 |
Why?
|
Catheterization | 1 | 2003 | 1432 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2008 | 2981 | 0.040 |
Why?
|
Stem Cells | 1 | 2010 | 3523 | 0.040 |
Why?
|
Lymphokines | 1 | 2000 | 927 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2008 | 2622 | 0.040 |
Why?
|
Coronary Disease | 7 | 1988 | 5990 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2021 | 22053 | 0.030 |
Why?
|
Radiography | 2 | 2008 | 6965 | 0.030 |
Why?
|
Soft Tissue Neoplasms | 1 | 2005 | 1152 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 867 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2008 | 3696 | 0.030 |
Why?
|
Ganciclovir | 1 | 1997 | 252 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2005 | 1495 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2016 | 101 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2020 | 699 | 0.030 |
Why?
|
Heart Block | 1 | 1997 | 392 | 0.030 |
Why?
|
Obesity | 1 | 2018 | 12922 | 0.030 |
Why?
|
Consensus | 1 | 2005 | 3113 | 0.030 |
Why?
|
Risk Factors | 3 | 2017 | 74359 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6538 | 0.030 |
Why?
|
Pulmonary Veins | 1 | 2021 | 745 | 0.030 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2015 | 118 | 0.030 |
Why?
|
Aortic Valve | 1 | 2005 | 1996 | 0.030 |
Why?
|
Supine Position | 1 | 2015 | 205 | 0.030 |
Why?
|
Endothelins | 1 | 2014 | 127 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2000 | 869 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1998 | 1249 | 0.030 |
Why?
|
Bicycling | 1 | 2015 | 176 | 0.030 |
Why?
|
Systems Theory | 1 | 2014 | 57 | 0.030 |
Why?
|
Chronic Disease | 2 | 2008 | 9287 | 0.030 |
Why?
|
Prevalence | 1 | 2011 | 15687 | 0.030 |
Why?
|
Diastole | 1 | 2016 | 788 | 0.030 |
Why?
|
Lung Transplantation | 1 | 2003 | 1305 | 0.030 |
Why?
|
Collagen | 2 | 2016 | 2636 | 0.030 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2019 | 613 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17790 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2014 | 223 | 0.030 |
Why?
|
Coronary Circulation | 2 | 2018 | 1577 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2014 | 302 | 0.030 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1993 | 64 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1174 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2019 | 2222 | 0.030 |
Why?
|
Bronchi | 1 | 1997 | 848 | 0.030 |
Why?
|
Blood Circulation | 1 | 2013 | 249 | 0.030 |
Why?
|
Catheter-Related Infections | 1 | 2016 | 273 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 5643 | 0.030 |
Why?
|
Kenya | 1 | 2015 | 749 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2021 | 14372 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2014 | 590 | 0.020 |
Why?
|
Drug Resistance | 1 | 1998 | 1617 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15757 | 0.020 |
Why?
|
Pacemaker, Artificial | 1 | 1997 | 815 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2014 | 588 | 0.020 |
Why?
|
Biopsy | 1 | 2003 | 6771 | 0.020 |
Why?
|
Thyroglobulin | 1 | 1991 | 111 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2016 | 1167 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2015 | 2502 | 0.020 |
Why?
|
Pressure | 1 | 2013 | 1156 | 0.020 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2009 | 65 | 0.020 |
Why?
|
Chest Pain | 1 | 1997 | 1106 | 0.020 |
Why?
|
Hemorrhage | 1 | 2022 | 3600 | 0.020 |
Why?
|
Technetium Tc 99m Medronate | 1 | 1990 | 131 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2015 | 1436 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2010 | 397 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2016 | 965 | 0.020 |
Why?
|
Heart Rate | 2 | 2019 | 4179 | 0.020 |
Why?
|
Bone Neoplasms | 2 | 1993 | 2532 | 0.020 |
Why?
|
Gallium Radioisotopes | 1 | 1990 | 195 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 2013 | 983 | 0.020 |
Why?
|
Gated Blood-Pool Imaging | 1 | 2008 | 42 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25942 | 0.020 |
Why?
|
Cell Line | 1 | 2003 | 15620 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1259 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2013 | 1809 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2021 | 5125 | 0.020 |
Why?
|
Shock | 1 | 2010 | 317 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1139 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5201 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2008 | 26181 | 0.020 |
Why?
|
Osteosarcoma | 1 | 1993 | 897 | 0.020 |
Why?
|
Ventilator Weaning | 1 | 2008 | 161 | 0.020 |
Why?
|
Iodine Radioisotopes | 1 | 1991 | 1032 | 0.020 |
Why?
|
Total Quality Management | 1 | 2008 | 265 | 0.020 |
Why?
|
Heart Arrest | 1 | 1997 | 1506 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6544 | 0.020 |
Why?
|
Respiration | 1 | 2013 | 1654 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1652 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2417 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 7408 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1998 | 4357 | 0.020 |
Why?
|
Mitral Valve | 1 | 2015 | 1486 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 5797 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9335 | 0.020 |
Why?
|
Sensitivity and Specificity | 3 | 2009 | 14660 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2007 | 915 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9585 | 0.020 |
Why?
|
Infant | 2 | 2019 | 36060 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 1991 | 785 | 0.020 |
Why?
|
Blotting, Western | 2 | 2005 | 5039 | 0.020 |
Why?
|
Health Plan Implementation | 1 | 2008 | 335 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4264 | 0.020 |
Why?
|
Tetrahydroisoquinolines | 1 | 2005 | 81 | 0.020 |
Why?
|
Ganglia, Spinal | 1 | 1988 | 523 | 0.020 |
Why?
|
Dendrites | 1 | 1988 | 475 | 0.020 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1985 | 117 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 1988 | 1121 | 0.020 |
Why?
|
Ribonucleases | 1 | 2005 | 277 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6828 | 0.010 |
Why?
|
Peritonitis | 1 | 2007 | 369 | 0.010 |
Why?
|
Antiviral Agents | 1 | 1997 | 3061 | 0.010 |
Why?
|
Vasoconstrictor Agents | 1 | 2008 | 651 | 0.010 |
Why?
|
Physical Endurance | 1 | 2006 | 363 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 2013 | 1475 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2007 | 1753 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2007 | 580 | 0.010 |
Why?
|
Culture Media | 1 | 2005 | 900 | 0.010 |
Why?
|
Perfusion | 1 | 2008 | 1376 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7818 | 0.010 |
Why?
|
Tretinoin | 1 | 2005 | 519 | 0.010 |
Why?
|
Collagen Type I | 1 | 2005 | 616 | 0.010 |
Why?
|
Caspases | 1 | 2005 | 878 | 0.010 |
Why?
|
Education, Medical | 1 | 2013 | 1727 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2014 | 3448 | 0.010 |
Why?
|
Heart Aneurysm | 1 | 1981 | 115 | 0.010 |
Why?
|
Movement | 1 | 1988 | 1474 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6238 | 0.010 |
Why?
|
Technetium | 1 | 1981 | 321 | 0.010 |
Why?
|
Fibroblast Growth Factor 10 | 1 | 2000 | 31 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6218 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 2008 | 1328 | 0.010 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2000 | 59 | 0.010 |
Why?
|
Heart Function Tests | 1 | 1981 | 319 | 0.010 |
Why?
|
Regression Analysis | 1 | 2009 | 6360 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2000 | 151 | 0.010 |
Why?
|
Child | 2 | 2019 | 79806 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1983 | 752 | 0.010 |
Why?
|
Walking | 1 | 2006 | 1189 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2007 | 2209 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2000 | 748 | 0.010 |
Why?
|
Growth Substances | 1 | 2000 | 768 | 0.010 |
Why?
|
Biomedical Research | 1 | 2013 | 3426 | 0.010 |
Why?
|
Hospitalization | 1 | 2018 | 10790 | 0.010 |
Why?
|
Thyroid Neoplasms | 1 | 1991 | 2332 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2000 | 594 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4899 | 0.010 |
Why?
|
Length of Stay | 1 | 2010 | 6479 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2000 | 2558 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2000 | 924 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42063 | 0.010 |
Why?
|
Critical Illness | 1 | 2008 | 2709 | 0.010 |
Why?
|
RNA | 1 | 2005 | 2722 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2005 | 2634 | 0.010 |
Why?
|
Fibroblasts | 1 | 2005 | 4090 | 0.010 |
Why?
|
Escherichia coli | 1 | 2007 | 4219 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29932 | 0.010 |
Why?
|
Wound Healing | 1 | 2005 | 2788 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13981 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1991 | 6315 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8950 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2008 | 4925 | 0.010 |
Why?
|
Antibodies | 1 | 2000 | 2421 | 0.010 |
Why?
|
Cytokines | 1 | 2007 | 7343 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2000 | 11071 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12766 | 0.010 |
Why?
|
Citric Acid | 1 | 1990 | 123 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 1979 | 2272 | 0.010 |
Why?
|
Supination | 1 | 1989 | 68 | 0.010 |
Why?
|
Thyroxine-Binding Proteins | 1 | 1967 | 25 | 0.000 |
Why?
|
Globulins | 1 | 1967 | 19 | 0.000 |
Why?
|
Porphyrias | 1 | 1967 | 58 | 0.000 |
Why?
|
False Positive Reactions | 1 | 1989 | 956 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 1990 | 13630 | 0.000 |
Why?
|
Thyroid Function Tests | 1 | 1967 | 289 | 0.000 |
Why?
|
Krypton | 1 | 1985 | 21 | 0.000 |
Why?
|
Macrophages | 1 | 2000 | 5745 | 0.000 |
Why?
|
Dilatation, Pathologic | 1 | 1987 | 527 | 0.000 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 1985 | 66 | 0.000 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1993 | 3529 | 0.000 |
Why?
|
Coronary Angiography | 2 | 1987 | 4563 | 0.000 |
Why?
|
Kymography | 1 | 1981 | 12 | 0.000 |
Why?
|
Cell Division | 1 | 1988 | 4463 | 0.000 |
Why?
|
False Negative Reactions | 1 | 1981 | 573 | 0.000 |
Why?
|
Axons | 1 | 1988 | 1673 | 0.000 |
Why?
|
Constriction, Pathologic | 1 | 1983 | 1098 | 0.000 |
Why?
|
Electrocardiography | 2 | 1983 | 6414 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1981 | 1628 | 0.000 |
Why?
|
Fluoroscopy | 1 | 1981 | 948 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1979 | 15697 | 0.000 |
Why?
|
Myocardial Infarction | 3 | 1981 | 11891 | 0.000 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 1987 | 3340 | 0.000 |
Why?
|
Hypothermia, Induced | 1 | 1979 | 758 | 0.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1993 | 11712 | 0.000 |
Why?
|
Cost-Benefit Analysis | 1 | 1981 | 5508 | 0.000 |
Why?
|